Paid Clinical Trials in Indianapolis, IN

As of July 2026, 861 paid clinical trials are recruiting in Indianapolis, Indiana. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

766 clinical trials

Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients

for Coagulopathy

1 location in Indianapolis

Sponsor: Indiana University

Sex: All·Age: 3 Months - 18

Code: NCT05874843·Recruiting·Listed May 2023

Apply to this trial

Preoperative Corticosteroids in Autoimmune Thyroid Disease

for Graves Disease

3 locations in Indianapolis

Sponsor: Indiana University

Sex: All·Age: 18+

Code: NCT05435547·Phase 4·Recruiting·Listed Jun 2022

Apply to this trial

Pilot RCT of Self-stigma Treatment for First Episode Psychosis

for First Episode Psychosis

1 location in Indianapolis

Sponsor: John Jay College of Criminal Justice, City University of New York

Sex: All·Age: 15 - 24

Code: NCT04889911·Recruiting·Listed May 2021

Apply to this trial

Critical Health Assessment and Outcomes Score/Study

for Critical Illness

Sites in Indianapolis +2 more locations

Sponsor: Johns Hopkins University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT02766166·Recruiting·Listed May 2016

Apply to this trial

Predict Tooth Wear

for Prediction of Tooth Wear

1 location in Indianapolis

Sponsor: Hospices Civils de Lyon

Sex: All·Age: 18 - 80

Code: NCT06681844·Recruiting·Listed Nov 2024

Apply to this trial

The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families

for Mental Health

Sites in Indianapolis, Fort Wayne & Notre Dame

Sponsor: University of Notre Dame

Sex: All·Age: 4+·Accepts healthy volunteers

Code: NCT04980794·Recruiting·Listed Jul 2021

Apply to this trial

Hemlibra in Mild Hemophilia A

for Factor VIII Deficiency, Congenital

1 location in Indianapolis

Sponsor: Indiana Hemophilia &Thrombosis Center, Inc.

Sex: Male·Age: 5 - 45

Code: NCT04567511·Phase 4·Recruiting·Listed Sep 2020

Apply to this trial

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

for Weight Management

Sites in Indianapolis +54 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07667803·Phase 3·Recruiting·Listed Jun 25, 2026

Apply to this trial

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

for Treatment-resistant Depression (TRD)

Sites in Indianapolis +37 more locations

Sponsor: Alto Neuroscience

Sex: All·Age: 18 - 75

Code: NCT07553637·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for Gastric Cancer

Drug: Sonesitatug vedotin

Sites in Indianapolis +71 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07431281·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for Biliary Tract Cancer

Drug: Rilvegostomig

Sites in Indianapolis +34 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07221253·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for Epithelial Ovarian Cancer

Sites in Indianapolis, Fort Wayne +37 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT07218809·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes

for Primary Biliary Cholangitis

Sites in Indianapolis +2 more locations

Sponsor: Zydus Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT07216235·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

PSMA PET Combined With MRI for the Detection of PCa

for PCA

Sites in Indianapolis +15 more locations

Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited

Sex: Male·Age: 18+·Accepts healthy volunteers

Code: NCT07052214·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

for Endometrial Cancer

Sites in Indianapolis, Fort Wayne +65 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT07044336·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Study of BHV-1400 in IgA Nephropathy

for IgA Nephropathy

Sites in Indianapolis +13 more locations

Sponsor: Biohaven Therapeutics Ltd.

Sex: All·Age: 18 - 65

Code: NCT07054684·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

for Growth Hormone Deficiency (GHD)

Sites in Indianapolis +28 more locations

Sponsor: Lumos Pharma

Sex: All·Age: 3 - 11

Code: NCT06948214·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for Cardiovascular Disease

Sites in Indianapolis, Munster +294 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07000357·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for Hepatocellular Carcinoma

Drug: Rilvegostomig

Sites in Indianapolis +30 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06921785·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for Chronic Kidney Disease and Hypertension

Drug: Dapagliflozin

Sites in Indianapolis +116 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06742723·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for Metastatic Clear Cell Renal Cell Carcinoma

Drug: Cabozantinib

Sites in Indianapolis +41 more locations

Sponsor: Arcus Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07011719·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for Endometrial Carcinoma

Sites in Indianapolis, Carmel +325 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

for Transthyretin Amyloidosis

Sites in Indianapolis +29 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06465810·Recruiting·Listed Jun 2024

Apply to this trial

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

for Testicular Cancer

1 location in Indianapolis

Sponsor: Indiana University

Sex: Male·Age: 18 - 99

Code: NCT05611307·Recruiting·Listed Nov 2022

Apply to this trial

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

for Asthma

Sites in Indianapolis +89 more locations

Sponsor: AstraZeneca

Sex: All·Age: 12 - 17

Code: NCT06307665·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for Graves' Disease

Drug: IMVT-1402

Sites in Indianapolis +57 more locations

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18 - 75

Code: NCT06727604·Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

for Head and Neck Squamous Cell Carcinoma

Drug: Petosemtamab

Sites in Indianapolis +60 more locations

Sponsor: Merus B.V.

Sex: All·Age: 18+

Code: NCT06496178·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

for Chronic Obstructive Pulmonary Disease (COPD)

Sites in Indianapolis, Evansville +60 more locations

Sponsor: AstraZeneca

Sex: All·Age: 40 - 80

Code: NCT06878261·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for Acute Coronary Syndrome

Sites in Indianapolis, Richmond +146 more locations

Sponsor: DalCor Pharmaceuticals

Sex: All·Age: 45+

Code: NCT05918861·Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

Product Surveillance Registry

for Cardiac Rhythm Disorders

Sites in Indianapolis, Evansville +127 more locations

Sponsor: Medtronic

Sex: All·Age: All ages

Code: NCT01524276·Recruiting·Listed Feb 2012

Apply to this trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

for Cutaneous Lupus Erythematosus (CLE)

Sites in Indianapolis +12 more locations

Sponsor: Ventus Therapeutics U.S., Inc.

Sex: All·Age: 18 - 80

Code: NCT07260877·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

for Heart Failure

Drug: Dapagliflozin

Sites in Indianapolis, Richmond +172 more locations

Sponsor: AstraZeneca

Sex: All·Age: 40+

Code: NCT06677060·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

for Arrhythmia

Sites in Indianapolis, Evansville +83 more locations

Sponsor: Medtronic

Sex: All·Age: All ages

Code: NCT00271180·Recruiting·Listed Dec 2005

Apply to this trial

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

for Growth Hormone Deficiency

Sites in Indianapolis +26 more locations

Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All·Age: All ages

Code: NCT05820672·Recruiting·Listed Apr 2023

Apply to this trial

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

for Liver Diseases, Alcoholic

Sites in Indianapolis +25 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 70

Code: NCT06613698·Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

for Melanoma (Skin)

Sites in Indianapolis +4 more locations

Sponsor: Hummingbird Bioscience

Sex: All·Age: 18+

Code: NCT06956690·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

for Androgenetic Alopecia (AGA)

Sites in Indianapolis, Plainfield +68 more locations

Sponsor: Veradermics, Inc.

Sex: Female·Age: 18 - 65

Code: NCT07146022·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

for Growth Hormone Deficiency

Sites in Indianapolis +26 more locations

Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All·Age: 1 - 18

Code: NCT05775523·Recruiting·Listed Mar 2023

Apply to this trial

Exploring the Acute and Dynamic Relationships Between Movement and Pain in Older Adults With Musculoskeletal Pain

for Older People

1 location in Indianapolis

Sponsor: Indiana University

Sex: All·Age: 55 - 85

Code: NCT06886906·Recruiting·Listed Mar 2025

Apply to this trial

Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome

for Netherton Syndrome

Sites in Indianapolis +3 more locations

Sponsor: Quoin Pharmaceuticals

Sex: All·Age: 14+

Code: NCT05789056·Phase 2, Phase 3·Recruiting·Listed Mar 2023

Apply to this trial